SCHEMBL17885210

SCHEMBL17885210

c1ccc2c(c1)oc1ccc(-c3ccc(-c4ccc5[nH]c6ccc(-c7cccc8oc9ccccc9c78)cc6c5c4)cc3)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 1/20 0.45
▸ SENP7 Q9BQF6 1/20 0.45
▸ SENP6 Q9GZR1 1/20 0.45
▸ ALOX5 P09917 1/20 0.41
▸ HCRTR1 O43613 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CHEK2 O96017 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ HSP90AB1 P08238 1/20 0.39
▸ PLA2G2A P14555 4/20 0.38
▸ PLA2G4A P47712 4/20 0.38
▸ CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17885202 0.93 CASP3 (0.43) CASP3SENP7SENP6ALOX5HCRTR1
SCHEMBL17885394 0.90 AHR (0.44) CASP3SENP7SENP6ALOX5HCRTR1
SCHEMBL26055933 0.90 CASP3 (0.43) CASP3SENP7SENP6ALOX5HCRTR1
SCHEMBL26055957 0.88 CDK4 (0.41) CASP3SENP7SENP6ALOX5HCRTR1
SCHEMBL29388168 0.87 CASP3 (0.51) CASP3SENP7SENP6HCRTR1KDM4E
SCHEMBL15962623 0.87 CASP3 (0.51) CASP3SENP7SENP6HCRTR1KDM4E
SCHEMBL20715159 0.87 CASP3 (0.51) CASP3SENP7SENP6HCRTR1KDM4E
SCHEMBL28821558 0.87 MAPT (0.50) CASP3SENP7SENP6ALOX5KDM4E
SCHEMBL31288261 0.86 AHR (0.46) CASP3SENP7SENP6ALOX5HCRTR1
SCHEMBL16500873 0.86 AHR (0.48) CASP3SENP7SENP6HCRTR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3237409-B1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS MERCK PATENT GMBH (DE) 2022-01-05 — — EP disclosed
US-20190044071-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS MERCK PATENT GMBH (DE) 2019-02-07 — — US disclosed
WO-2016102040-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS MERCK PATENT GMBH (DE) 2016-06-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190044071-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS BRD3, BRPF3, DDT CASP3 1113/4885SENP7 3524/4885SENP6 4315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback